Abstract
The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / pharmacology*
-
Adrenergic beta-Antagonists / therapeutic use
-
Aged
-
Anxiety / complications
-
Anxiety / psychology
-
Cognition / drug effects*
-
Coronary Artery Disease / complications
-
Coronary Artery Disease / drug therapy*
-
Coronary Artery Disease / psychology
-
Cross-Sectional Studies
-
Depression / complications
-
Depression / psychology
-
Female
-
Humans
-
Learning / drug effects*
-
Male
-
Middle Aged
-
Neuropsychological Tests
Substances
-
Adrenergic beta-Antagonists